Patents Assigned to BICA THERAPEUTICS INC.
  • FUSION PROTEIN CONTAINING ERYTHROPOIETIN POLYPEPTIDE
    Publication number: 20230357341
    Abstract: The present invention relates to a fusion protein containing an erythropoietin polypeptide fused to the Fc region of mammal-derived IgG (hereinafter to be also abbreviated as EPO-Fc fusion protein). The fusion protein in which erythropoietin polypeptide has the amino acid sequence shown in SEQ ID NO: 9 or 10, and the Fc region has the amino acid sequence shown in SEQ ID NO: 3 or 4 is more superior in the property and activity and can be obtained at a high yield.
    Type: Application
    Filed: June 9, 2021
    Publication date: November 9, 2023
    Applicant: BICA THERAPEUTICS INC.
    Inventors: Ryota NAKAO, Yoshikatsu IZUMI, Kunihiro HATTORI